Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 2004

View Archived Issues

Nuvelo reports preliminary data from phase II study of alfimeprase in PAO

Preliminary data on long-term rosiglitazone for Cushing's disease

Subcutaneous TH-9507 shows promise for chronic wasting conditions

LY-156735 found effective and safe in primary insomnia

Potential benefits of BW-755C in metabolic dysfunction caused by high fructose diet in rats

Novartis seeks European approval of Xolair for severe allergic asthma

Canadian approval for initiation of phase II study of I.E.T. for MS

Approvable letter for Agilect in Parkinson's disease

Indaflex demonstrates significant localized antiinflammatory activity

Provalis signs vaccine option agreement with Chiron Vaccines

GlaxoSmithKline renews Crucell PER.C6 license agreement

Nymox pursues new approaches to combating Alzheimer's disease

Phosmidosine derivatives with antitumor activity presented by Sankyo

Solvay researchers describe series of 5-HT3 receptor antagonists

Aventis Pharma scientists design new protein kinase inhibitors

Boehringer Ingelheim presents compounds for inflammatory and obstructive airways diseases

Cadila claims aralkyl derivatives as antidiabetic, hypolipidemic and hypocholesterolemic compounds

Antifungal triazole prodrugs described in Sankyo patent

First description of lipoptosis using IgM antibody SAM-6

Tropical plant derivative induces mitochondria-dependent apoptosis in vitro

PARG inhibitor effective in vivo in septic shock-like syndrome, PARG may be novel therapeutic target

HKI-272 shows promise in the treatment of HER-2-positive tumors

Greater patient satisfaction achieved with inhaled insulin over subcutaneous insulin in diabetes

Patent claims new method to treat GI disorders with duloxetine

PROactive trial evaluates cardiovascular effects of pioglitazone in diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...